Everist Genomics, Inc.
Everist Genomics, Inc. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20120185174 | Prognostic Signature for Colorectal Cancer Recurrance - An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expression of the nucleic acid sequences of SEQ ID NOS: 1, 2, 3, 4, and 5. | 07-19-2012 |